The ability to rationally target disease-causing mutations has been made possible with programmable nucleases with the clustered, regularly interspaced short palindromic repeats/Cas9 system representing a facile platform for individualized gene-based medicine. In this study we employed footprint-free reprogramming of fibroblasts from a patient with mutations to the Fanconi anemia I (FANCI) gene to generate induced pluripotent stem cells (iPSCs). This process was accomplished without gene complementation and the resultant iPSCs were able to be gene corrected in a robust manner using the Cas9 nickase. The self-renewing iPSCs that were maintained under feeder-free conditions were differentiated into cells with characteristics of definitive hematopoiesis. This defined and highly efficient procedure employed small molecule modulation of the hematopoietic differentiation pathway and a vascular induction technique to generate hematopoietic progenitors. In sum, our results demonstrate the ability to induce patient-derived FA cells to pluripotency for patient-specific therapeutic cell derivation.
Get full access to this article
View all access options for this article.
References
1.
CattoglioC, FacchiniG, SartoriD, AntonelliA, MiccioA, CassaniB, SchmidtM, von KalleC, HoweS, et al. (2007). Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood, 110:1770–1778.
2.
Hacein-Bey-AbinaS, GarrigueA, WangGP, SoulierJ, LimA, MorillonE, ClappierE, CaccavelliL, DelabesseE, et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest, 118:3132–3142.
3.
Hacein-Bey-AbinaS, Von KalleC, SchmidtM, McCormackMP, WulffraatN, LeboulchP, LimA, OsborneCS, PawliukR, et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302:415–419.
4.
OsorioA, BoglioloM, FernandezV, BarrosoA, de la HoyaM, CaldesT, LasaA, Ramon y CajalT, SantamarinaM, et al. (2013). Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. Hum Mutat, 34:1615–1618.
5.
BoglioloM, SchusterB, StoepkerC, DerkuntB, SuY, RaamsA, TrujilloJP, MinguillonJ, RamirezMJ, et al. (2013). Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet, 92:800–806.
6.
RioP, BanosR, LombardoA, Quintana-BustamanteO, AlvarezL, GarateZ, GenoveseP, AlmarzaE, ValeriA, et al. (2014). Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med, 6:835–848.
7.
CeccaldiR, SarangiP and D'AndreaAD. (2016). The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol, 17:337–349.
OsbornMJ, GabrielR, WebberBR, DeFeoAP, McElroyAN, JarjourJ, StarkerCG, WagnerJE, JoungJK, et al. (2015). Fanconi anemia gene editing by the CRISPR/Cas9 system. Hum Gene Ther, 26:114–126.
15.
IshikawaF, LivingstonAG, MinamiguchiH, WingardJR and OgawaM. (2003). Human cord blood long-term engrafting cells are CD34+ CD38. Leukemia, 17:960–964.
16.
MaliP, YangL, EsveltKM, AachJ, GuellM, DiCarloJE, NorvilleJE and ChurchGM. (2013). RNA-guided human genome engineering via Cas9. Science, 339:823–826.
17.
GibsonDG, YoungL, ChuangRY, VenterJC, HutchisonCA3rd and SmithHO. (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods, 6:343–345.
18.
TolarJ, XiaL, LeesCJ, RiddleM, McElroyA, KeeneDR, LundTC, OsbornMJ, MarinkovichMP, BlazarBR and WagnerJE. (2013). Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol, 133:562–565.
19.
TolarJ, XiaL, RiddleMJ, LeesCJ, EideCR, McElmurryRT, TiteuxM, OsbornMJ, LundTC, et al. (2011). Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol, 131:848–856.
TolarJ, ParkIH, XiaL, LeesCJ, PeacockB, WebberB, McElmurryRT, EideCR, OrchardPJ, et al. (2011). Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood, 117:839–847.
22.
Lopez-OnievaL, MontesR, LamoldaM, RomeroT, AyllonV, LozanoML, VicenteV, RiveraJ, Ramos-MejiaV and RealPJ. (2016). Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene. Stem Cell Res, 16:692–695.
23.
GuschinDY, WaiteAJ, KatibahGE, MillerJC, HolmesMC and RebarEJ. (2010). A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol, 649:247–256.
24.
HartigSM. (2013). Basic image analysis and manipulation in ImageJ. Curr Protoc Mol Biol, Chapter 14:Unit14:15.
25.
SmogorzewskaA, MatsuokaS, VinciguerraP, McDonaldER3rd, HurovKE, LuoJ, BallifBA, GygiSP, HofmannK, D'AndreaAD and ElledgeSJ. (2007). Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129:289–301.
26.
WhitneyMA, SaitoH, JakobsPM, GibsonRA, MosesRE and GrompeM. (1993). A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet, 4:202–205.
27.
HsuPD, ScottDA, WeinsteinJA, RanFA, KonermannS, AgarwalaV, LiY, FineEJ, WuX, et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 31:827–832.
LiuGH, SuzukiK, LiM, QuJ, MontserratN, TarantinoC, GuY, YiF, XuX, et al. (2014). Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun, 5:4330.
30.
MedvinskyA, RybtsovS and TaoudiS. (2011). Embryonic origin of the adult hematopoietic system: advances and questions. Development, 138:1017–1031.
31.
KellerG, KennedyM, PapayannopoulouT and WilesMV. (1993). Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol, 13:473–486.
32.
SturgeonCM, DitadiA, AwongG, KennedyM and KellerG. (2014). Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol, 32:554–561.
33.
MadhuV, DigheAS, CuiQ and DealDN. (2016). Dual inhibition of Activin/Nodal/TGF-beta and BMP signaling pathways by SB431542 and dorsomorphin induces neuronal differentiation of human adipose derived stem cells. Stem Cells Int, 2016:1035374.
34.
DuJ, WuY, AiZ, ShiX, ChenL and GuoZ. (2014). Mechanism of SB431542 in inhibiting mouse embryonic stem cell differentiation. Cell Signal, 26:2107–2116.
35.
WuY, AiZ, YaoK, CaoL, DuJ, ShiX, GuoZ and ZhangY. (2013). CHIR99021 promotes self-renewal of mouse embryonic stem cells by modulation of protein-encoding gene and long intergenic non-coding RNA expression. Exp Cell Res, 319:2684–2699.
36.
SandlerVM, LisR, LiuY, KedemA, JamesD, ElementoO, ButlerJM, ScanduraJM and RafiiS. (2014). Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature, 511:312–318.
37.
SakuraiY, KomatsuK, AgematsuK and MatsuokaM. (2009). DNA double strand break repair enzymes function at multiple steps in retroviral infection. Retrovirology, 6:114.
38.
BaekelandtV, ClaeysA, CherepanovP, De ClercqE, De StrooperB, NuttinB and DebyserZ. (2000). DNA-Dependent protein kinase is not required for efficient lentivirus integration. J Virol, 74:11278–11285.
39.
WalterD, LierA, GeiselhartA, ThalheimerFB, HuntschaS, SobottaMC, MoehrleB, BrocksD, BayindirI, et al. (2015). Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature, 520:549–552.
40.
OsbornMJ, WebberBR, KnippingF, LonetreeCL, TennisN, DeFeoAP, McElroyAN, StarkerCG, LeeC, et al. (2016). Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9 and megaTAL nucleases. Mol Ther, 24:570–581.
41.
KanY, RuisB, LinS and HendricksonEA. (2014). The mechanism of gene targeting in human somatic cells. PLoS Genet, 10:e1004251.
42.
KleinstiverBP, PrewMS, TsaiSQ, NguyenNT, TopkarVV, ZhengZ and JoungJK. (2015). Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol, 33:1293–1298.
HouZ, ZhangY, PropsonNE, HowdenSE, ChuLF, SontheimerEJ and ThomsonJA. (2013). Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A, 110:15644–15649.
45.
ShenB, ZhangW, ZhangJ, ZhouJ, WangJ, ChenL, WangL, HodgkinsA, IyerV, HuangX and SkarnesWC. (2014). Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods, 11:399–402.
46.
CertoMT, RyuBY, AnnisJE, GaribovM, JarjourJ, RawlingsDJ and ScharenbergAM. (2011). Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods, 8:671–676.
47.
GenoveseP, SchiroliG, EscobarG, Di TomasoT, FirritoC, CalabriaA, MoiD, MazzieriR, BoniniC, et al. (2014). Targeted genome editing in human repopulating haematopoietic stem cells. Nature, 510:235–240.
48.
WangJ, ExlineCM, DeClercqJJ, LlewellynGN, HaywardSB, LiPW, ShivakDA, SuroskyRT, GregoryPD, HolmesMC and CannonPM. (2015). Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nat Biotechnol, 33:1256–1263.
49.
VodyanikMA, ThomsonJA and SlukvinII. (2006). Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood, 108:2095–2105.
50.
GaoJ, YanXL, LiR, LiuY, HeW, SunS, ZhangY, LiuB, XiongJ and MaoN. (2010). Characterization of OP9 as authentic mesenchymal stem cell line. J Genet Genomics, 37:475–482.
51.
MohtashamiM, ShahDK, KianizadK, AwongG and Zuniga-PfluckerJC. (2013). Induction of T-cell development by Delta-like 4-expressing fibroblasts. Int Immunol, 25:601–611.
52.
KennedyM, AwongG, SturgeonCM, DitadiA, LaMotte-MohsR, Zúñiga-PflückerJC and KellerG. (2012). T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep, 2:1722–1735.
53.
GilmoreGL, DePasqualeDK, ListerJ and ShadduckRK. (2000). Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells. Exp Hematol, 28:1297–1305.
FrockRL, HuJ, MeyersRM, HoYJ, KiiE and AltFW. (2015). Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol, 33:179–186.
56.
GabrielR, LombardoA, ArensA, MillerJC, GenoveseP, KaeppelC, NowrouziA, BartholomaeCC, WangJ, et al. (2011). An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol, 29:816–823.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
